Definitive Contract 75A50123C00022
Award Date
7/6/23
Potential Completion Date
8/6/34
Potential Value
$143M
Awardee
Melinta Therapeutics, LLC
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Sharing
Place of Performance
Washington, DC 20001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $323,554,976.00 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Paratek Pharmaceuticals, Inc. for the development of an antibiotic to treat a biothreat indication. The contract has an ultimate completion date of December 17, 2029 and was awarded on December 18, 2019. This contract is not associated with a set-aside program.</p>
This federal contract award, valued at $1,175.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of the antibiotic medication Bicillin L-A in 2mL vials, with a completion date of September 11, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Spero Therapeutics, Inc. for the advanced research and development of SPR994, an oral carbapenem antibiotic to treat drug-resistant Gram-negative bacterial infections. The $43,372,809.00 cost-sharing contract has a period of performance through December 31, 2025. The contract was not set aside and originated from a Broad Agency Announcement (BAA) seeking proposals to develop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,153,890 units of Penicillin G Sodium, a critical antibiotic medication, with a ceiling value of $3,255.03. The contract has an ultimate completion date of February 5, 2025 and was awarded on February 4, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It...
This federal contract award is for the delivery of 1,200,000 units of the antibiotic medication Bicillin L-A, 2ml, to the Defense Logistics Agency (DLA). The $76,391.25 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 13, 2024 with a completion date of November 14, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based antibiotic, to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, is a firm-fixed price delivery order valued at $2,246.04. It has an ultimate completion date of November 29, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution firm that specializes in supplying medical products to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,072.54 firm fixed-price delivery order contract is for the supply of 1,200,000 units of Bicillin L-A, a brand-name antibiotic medication, with a completion date of February 27, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award, with a ceiling value of $10,162.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order to supply 2,400,000 units of Bicillin L-A, a penicillin-based antibiotic, to support military healthcare needs. The contract has an ultimate completion date of July 30, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and...
This is a $27,032,719.27 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Spero Therapeutics, Inc. to advance the clinical and non-clinical development of an antibiotic candidate. The contract is not set aside. The contract originated from a NIAID Broad Agency Announcement (BAA) soliciting proposals for the advanced development of vaccine candidates, therapeutic products, and diagnostics to address biodefense, antimicrobial...
This federal contract award, valued at $432,146.23, was issued by the Department of Defense's Medical Supply Chain (also known as the Defense Logistics Agency Troop Support Medical branch) to Mckesson Corporation, a healthcare services and information technology company. The contract is a firm fixed price delivery order, without any set-aside designation, for the provision of pharmaceutical products such as penicillin injections and alvimopan capsules to support federal health programs and...